Clincosm LogoSign in Get a demo

hepatocellular carcinoma by bclc stage

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou (Bevacizumab Biosimilar QL 1101)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Bevacizumab Biosimilar QL 1101
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 20, 2023

Hepatocellular Carcinoma by BCLC Stage Trial in Rennes (Tislelizumab)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Rennes, France
    Centre Eugene Marquis
Jan 16, 2023

Unresectable Hepatocellular Carcinoma, Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou, Guanzhou, Changsha (Hepatic

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Hepatocellular Carcinoma by BCLC Stage
  • Hepatic Arterial Infusion(mFOLFOX7) combined with Bevacizumab and Sintilimab
  • Guangzhou, Guangdong, China
  • +4 more
May 4, 2022

Hepatocellular Carcinoma After Transarterial Chemoembolization

Completed
  • Hepatocellular Carcinoma
  • Hepatocellular Carcinoma by BCLC Stage
  • Transarterial Chemoembolization
  • (no location specified)
Mar 2, 2021

Hepatocellular Carcinoma by BCLC Stage Trial in Wuhan (anatomical liver resection)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • anatomical liver resection
  • Wuhan, Hubei, China
    Hepatic Surgery Center of Tongji Hospital
Aug 27, 2018

NSCLC Stage IIIB, NSCLC Stage IV, Hepatocellular Carcinoma by BCLC Stage Trial (Immune Killer Cells (IKC))

Completed
  • NSCLC Stage IIIB
  • +4 more
  • Immune Killer Cells (IKC)
  • (no location specified)
May 3, 2018